Interestingly, most of the CpG sites are more frequently methylated in LGG than GBM patients (19 out of 28; Fig. 2), suggesting that WNT6 locus may be globally hypomethylated during tumor progression. This evidence concerns the gene WNT6 and glioblastoma.